Response to apomorphine in early Parkinson's disease

被引:0
|
作者
Vitale, C
Marconi, R
Pellecchia, MT
Amboni, M
Bonavita, V
Barone, P
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P725
引用
收藏
页码:S254 / S254
页数:1
相关论文
共 50 条
  • [41] Apomorphine therapy in Parkinson's disease and future directions
    Titova, Nataliya
    Chaudhuri, K. Ray
    PARKINSONISM & RELATED DISORDERS, 2016, 33 : S56 - S60
  • [42] An evaluation of subcutaneous apomorphine for the treatment of Parkinson's disease
    Mueller, Thomas
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (14) : 1659 - 1665
  • [43] Continuous subcutaneous apomorphine monotherapy in Parkinson's disease
    Papuc, Ewa
    Trzciniecka, Olga
    Rejdak, Konrad
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2019, 26 (01) : 133 - 137
  • [44] Effects of apomorphine on visual functions in Parkinson's disease
    Büttner, T
    Müller, T
    Kuhn, W
    JOURNAL OF NEURAL TRANSMISSION, 2000, 107 (01) : 87 - 94
  • [45] Apomorphine Monotherapy for Parkinson's Disease: A Neglected Option?
    Desjardins, Clement
    Nilles, Christelle
    Devos, David
    Roze, Emmanuel
    JOURNAL OF MOVEMENT DISORDERS, 2023, 16 (03) : 328 - 330
  • [46] The role of subcutaneous infusion of apomorphine in Parkinson's disease
    Wenzel, Karoline
    Homann, Carl Nikolaus
    Fabbrini, Giovanni
    Colosimo, Carlo
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (07) : 833 - 843
  • [47] Apomorphine and Duodopa infusion therapy in Parkinson's disease
    Odin, Per
    Honig, Holger
    PSYCHOPHARMAKOTHERAPIE, 2007, 14 (03): : 96 - +
  • [48] Intermittent Subcutaneous Injections of Apomorphine in Parkinson's Disease
    Ceylan, Mustafa
    Gultekin, Murat
    Celik, Nazli Durmaz
    Samanci, Bedia
    Cakmakli, Gul Yalcin
    Yilmaz, Rezzak
    EURASIAN JOURNAL OF MEDICINE, 2022, 54 : S71 - S76
  • [49] Apomorphine for Parkinson's disease: pharmacologic and clinical considerations
    Wagner, Maxwell J.
    Daniel, Charles P.
    Plaisance, Connor J.
    Borne, Grant E.
    Ahmadzadeh, Shahab
    Shekoohi, Sahar
    Kaye, Alan D.
    EXPERT OPINION ON EMERGING DRUGS, 2023, 28 (04) : 275 - 281
  • [50] Intermittent subcutaneous apomorphine therapy in Parkinson's disease
    Factor, SA
    NEUROLOGY, 2004, 62 (06) : S12 - S17